4//SEC Filing
KEYSER D JEFFREY 4
Accession 0001493152-25-014614
CIK 0001763950other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:05 PM ET
Size
12.6 KB
Accession
0001493152-25-014614
Insider Transaction Report
Form 4
KEYSER D JEFFREY
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-15+9,135→ 9,135 totalExercise: $5.04Exp: 2030-06-14→ Common Stock (9,135 underlying) - Award
Stock Option (Right to Buy)
2021-11-04+3,200→ 3,200 totalExercise: $5.04Exp: 2031-11-03→ Common Stock (3,200 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-06-15−9,135→ 0 totalExercise: $15.00Exp: 2030-06-14→ Common Stock (9,135 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-11-04−3,200→ 0 totalExercise: $10.32Exp: 2031-11-03→ Common Stock (3,200 underlying)
Footnotes (2)
- [F1]The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and provides for vesting in equal monthly increments over a 36-month period commencing July 15, 2020.
- [F2]The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 4, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing December 4, 2021.
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0001393516
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 4:05 PM ET
- Size
- 12.6 KB